[HTML][HTML] Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

Insights into new-onset autoimmune diseases after COVID-19 vaccination

M Guo, X Liu, X Chen, Q Li - Autoimmunity Reviews, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

OMICRON: Virology, immunopathogenesis, and laboratory diagnosis

M Bazargan, R Elahi… - The Journal of Gene …, 2022 - Wiley Online Library
Since its emersion, coronavirus disease 2019 (COVID‐19) has been a significant global
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …

An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active …

J Torales, O Cuenca-Torres, L Barrios, L Armoa-Garcia… - Vaccine, 2023 - Elsevier
Background Data from previous studies of the MVC-COV1901 vaccine, a subunit vaccine
against SARS-CoV-2 based on the stable prefusion spike protein (S-2P) adjuvanted with …

Immune memory to SARS-CoV-2 Omicron BA. 1 breakthrough infections: To change the vaccine or not?

MC van Zelm - Science immunology, 2022 - science.org
Immune memory to SARS-CoV-2 Omicron BA.1 breakthrough infections: To change the vaccine
or not? | Science Immunology news careers commentary Journals Science Science Log in …

[HTML][HTML] Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated …

TM Renner, B Akache, M Stuible, N Rohani… - Frontiers in …, 2023 - frontiersin.org
Liposomes composed of sulfated lactosyl archaeol (SLA) have been shown to be a safe and
effective vaccine adjuvant with a multitude of antigens in preclinical studies. In particular …

Serum neutralizing antibody titers 12 months after coronavirus disease 2019 messenger RNA vaccination: correlation to clinical variables in an adult, US population

M Zhao, R Slotkin, AH Sheth, L Pischel… - Clinical Infectious …, 2023 - academic.oup.com
Background We studied whether comorbid conditions affect strength and duration of
immune responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

New insights into human immune memory from SARS‐CoV‐2 infection and vaccination

GE Hartley, ESJ Edwards, RE O'Hehir, MC van Zelm - Allergy, 2022 - Wiley Online Library
Since early 2020, the world has been embroiled in an ongoing viral pandemic with SARS‐
CoV‐2 and emerging variants resulting in mass morbidity and an estimated 6 million deaths …

[HTML][HTML] Microfluidic particle counter visualizing mucosal antibodies against SARS-CoV-2 in the upper respiratory tract for rapid evaluation of immune protection

J Li, LT Chu, H Hartanto, G Guo, L Liu, J Wu, M Wu… - Lab on a Chip, 2024 - pubs.rsc.org
Mucosal antibodies in the upper respiratory tract are the earliest and most critical
responders to prevent respiratory infections, providing an indication for the rapid evaluation …

[HTML][HTML] Biology of the SARS-CoV-2 Coronavirus

RN Mingaleeva, NA Nigmatulina… - Biochemistry …, 2022 - Springer
New coronavirus infection causing COVID-19, which was first reported in late 2019 in China,
initiated severe social and economic crisis that affected the whole world. High frequency of …